Boris Guennewig
Visiting Scientist
Parkinsons Disease and Neurodegeneration
Garvan Institute of Medical Research
Australia
Biography
I was born in Emmerich am Rhein at the Dutch border of Germany and I started my studies with a scholarship in the “Job oriented Biotechnology” curriculum in Perugia/Italy, which was founded by 80 Universities and the European Union. This in general fantastic opportunity appeared to be an organizational catastrophe, with more cancelled lectures than given ones. So I decided to go back to Germany and start a conventional chemistry study, which turned out to be great fun and a thorough education in math, physics and of course chemistry.
Research Interest
Micro and long noncoding - RNA Bioinformatics Neurodegenerative Diseases
Publications
-
Boris Guennewig, Afzal M. Dogar, Luca F. R. Gebert, Martina Roos, Julian A. Zagalak, Valentina Vongrad, Karin J. Metzner and Jonathan Hall. Synthetic pre-microRNAs reveal dual-strand activity of miR-34a on TNF-alpha. RNA 2014; 20(1):61-75.
-
Harry Towbin, Philipp Wenter, Boris Guennewig and Jonathan Hall. Systematic screens of proteins binding to synthetic microRNA precursors. Nucleic Acid Research. 2012; 41(3): e47.
-
Afzal M. Dogar, Giuseppe Semplicio, Boris Guennewig and Jonathan Hall. Multiple microRNAs derived from chemically-synthesized precursors regulate thrombospondin 1 expression. Nucl Acid Therap. 2013; (in press)
